Unbiased Analysis of Today's Healthcare Issues

Archive for the 'Uncategorized' Category

Economic Burden of ACPA+ patients with Rheumatoid Arthritis

That is the topic of my most recent article in the Journal of Managed Care & Specialty Pharmacy along with co-authors Mahlet Gizaw Tebeka, Kwanza Price, Chad Patel, and Kaleb Michaud.  The abstract of the article–titled “The Economic Burden of ACPA-Positive Status Among Patients with Rheumatoid Arthritis“–is below. BACKGROUND: Anticitrullinated protein antibodies (ACPAs) are serological […]

Read the rest of this entry »

Quality of your (Social) Life

Many metrics purport to measure individuals quality of life.  Tools such as the EQ-5D and SF-36 do so largely based on functional status.  Using other surveys on individual preferences, one can estimate patient utility for any given functional status level (i.e,. EQ-5D or SF-36 score).  What these scores ignore, however, is the social component of […]

Read the rest of this entry »

Quotation of the Day

On this Fourth of July, I will actually quote a British man to describe the state of a country. “Healthy citizens are the greatest asset any country can have.” ― Winston S. Churchill

Read the rest of this entry »

Are multiple sclerosis treatments worth the cost? Comparing how treatment “value” is determined by five cost effectiveness analyses

by Daniel Kantor, Michelle Brauer and Jason Shafrin As drug prices continue to rise, many patients, payers and policymakers are asking whether the treatment benefits justify the cost. One method favored by health technology assessment (HTA) bodies for making this decision in a formal manner is to conduct a cost effectiveness analyses (CEA).  However, there […]

Read the rest of this entry »

Overview of the American Health Care Act (a.k.a. “Repeal and Replace”)

Before we get into the details of how the American Health Care Act bill will proposed to change the current system, let’s first talk about what is not changing.  In fact, while “repeal and replace” has a catchy ring to it, there is a lot that is staying the same.  As Ezra Klein of Vox notes, […]

Read the rest of this entry »

Links to start the week

Obamacare replacement? My drug problem. Do ACOs reduce post acute care use? Eating with 4 ingredients. MD Anderson benches Watson? Patient = partner.

Read the rest of this entry »

Patient and Physician Risk Preferences

Physicians are supposed to act as agents for patients, acting in their best interest. But a question is, how well do physician know patient preferences? How well do physician preferences reflect those of patients. Previous research indicates that for terminal diseases, patients are risk loving. My own recently published research (with co-authors Schwartz, Okoro and […]

Read the rest of this entry »

Friday Links

Outcomes-based contracting. Off the shelf CAR-T? Physician opioid prescribing. Regional variation in back surgery. Free health care?

Read the rest of this entry »

Friday Links

Superbugs. Pharma execs on Trump. US gov’t should buy Gilead? Artificial skin. Low cost private schools? Trump = Marxist? Plus check out the Health Wonk Review’s Inauguration Edition at Managed Care Matters.

Read the rest of this entry »

ISPOR Paper of the year

The ISPOR paper of the year award for best publication in Value in Health was given to Basch et al. (2016) for their study titled Methods for Developing Patient-Reported Outcome-Based Performance Measures (PRO-PMs).  The abstract is below. Objective: To recommend methods for assessing quality of care via patient-reported outcome-based performance measures (PRO-PMs) of symptoms, functional status, […]

Read the rest of this entry »